Lu Z, Yan K, Sheng Y, Rukonge PA, et al. Caution in Interpreting NOTCH1 Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma. J Clin Oncol 2025 Sep 11:JCO2501053. doi: 10.1200/JCO-25-01053.
PMID: 40934450